Aflibercept treatment in patients with diabetic macular edema
Abstract
The article provides a brief description of diabetic macular edema pathogenesis highlighting the role of inflammation, along with a short review of aflibercept trials in diabetic macular edema patients. Three clinical cases of diabetic macular edema treatment with aflibercept (Eylea) intravitreal injections in treatment-nave patients are described; therapy was performed for 1 year according to the scheme provided in the Summary of Product...
Paper Details
Title
Aflibercept treatment in patients with diabetic macular edema
Published Date
May 15, 2017
Journal
Volume
10
Issue
2
Pages
94 - 109
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History